BACKGROUND Risk stratification for ventricular fibrillation (VF) in patients with Brugada syndrome (BrS) remains controversial.
Introduction
Brugada syndrome (BrS) is an inherited arrhythmogenic disorder characterized by a typical Brugada-type ECG pattern of ST-segment elevation in the right precordial leads and a high risk of ventricular fibrillation (VF) or sudden cardiac death (SCD). 1 Primary prevention of SCD in BrS patients has been recognized as important; however, VF risk stratification in BrS remains challenging and controversial.
Several studies on VF occurrence prediction in BrS patients have been reported. [2] [3] [4] [5] [6] [7] [8] Spontaneous type 1 ECG (Sp1), history of syncope probably caused by ventricular arrhythmia, family history of SCD, positive late potential, Tpeak-Tend (Tp-e) dispersion in leads V 1 -V 6 , 9 QRS duration in lead V 6 , 5 r-J interval in lead V 2 , 5 fragmented QRS, 10 ventricular tachycardia/VF inducibility by programmed electrical stimulation (PES), and ventricular effective refractory period o200 ms on electrophysiologic study (EPS) 8 have been reported to be useful in identifying highrisk patients. However, individual prediction performances of these parameters were limited in discriminating BrS patients with VF high risk.
Some reports that combined clinical parameters may be helpful in risk stratification of BrS patients without a history of cardiac arrest. Delise et al 11, 12 reported that each single risk factor (Sp1 pattern, familial juvenile sudden death, and positive EPS) displayed limited specificity and positive predictive value for predicting VF, and presence of a basal type 1 ECG is able to identify subjects at higher risk in combination with other clinical risk factors including syncope, family history of SCD, and positive EPS increased risk. 11, 12 Okamura et al 13 reported that combined assessment of history of syncope, Sp1, and VF induction by PES are important for stratifying VF risk in BrS patients. More recently, we reported that elevated time-domain T-wave alternans (TWA) on ambulatory ECG is a high-risk marker of VF occurrence in BrS patients. 14 The purpose of this study was to develop a logistic regression model for VF risk stratification in BrS patients based on noninvasive examination.
Method
Study protocol of risk stratification of BrS patients using noninvasive scoring method A total of 143 patients diagnosed with BrS (140 men, mean age 46 ± 12 years) between January 2001 and December 2014 were retrospectively enrolled from 3 different institutions in Japan: 58 patients at Hiroshima University Hospital (56 male, mean age 45 ± 13 years, VF history in 15), 83 patients at Osaka City University Hospital (82 male, mean age 47 ± 13 years, VF history in 19) , and 2 patients at Kyorin University Hospital (2 male, age 37 and 43 years, VF history in 1). BrS was definitively diagnosed based on the 2014 HRS/EHRA/APHRS consensus statement. 15 All subjects were classified into 2 groups: the VF group, which included patients with documented VF (n ¼ 35), and the non-VF group, which comprised patients without prior documented VF (n ¼ 108). We compared clinical characteristics, type of Brugada ECG and other 12-lead ECG parameters, signal-averaged ECG parameters, and time-domain TWA between the VF and non-VF groups, and all possible risk factors were screened by univariate analysis. Thereafter, multivariate analysis was performed in all subjects, followed by assessment of the performance of the prediction model for VF risk by cross-validation.
The study was approved by the ethics review committee of the hospital. We prospectively followed the 143 BrS patients after their diagnosis of BrS and investigated the relationships between the subsequent VF events (appropriate shocks/VF recordings on implantable cardioverter-defibrillator [ICD]) during follow-up periods and the score of our logistic model.
Twelve-lead ECG findings
The 12-lead ECG was recorded at a paper speed of 25 mm/s and amplification of 1 cm/mV. The following parameters were measured for the 143 patients ( Figure 1 ): (1) r-J interval, defined as the time between the earliest deflection of the QRS complex and J wave 5 ; (2) Tp-e, measured in each precordial lead and obtained from the difference between QT interval and QT peak interval, using the tangent method to define the end of the T wave 16 ; (3) QT dispersion, defined as the difference between the maximum and minimum QT interval of the precordial leads; and (4) fragmented QRS complex, defined as 42 notches or multiple notches of the R wave or in the nadir of the S wave in at least 2 consecutive leads. 17 Because the ST configurations in the right precordial leads showed day-to-day variation, 45 ECGs were recorded on different days in each BrS patient. When an SP1 pattern was recorded at least once in the recorded ECGs of a BrS patient, that person was defined as having an SP1 pattern. We determined SP1 only in the right precordial leads, with V 1 and V 2 positioned in the 4th intercostal space. 
Signal-averaged ECG
A signal-averaged ECG was recorded and analyzed using the EP-705LP system (Fukuda Denshi, Tokyo, Japan). Three parameters were assessed using a computer algorithm: (1) total filtered QRS duration (f-QRS); (2) root mean square voltage of the terminal 40 ms of the f-QRS complexes (RMS 40 ); and (3) duration of low-amplitude signals o40 µV of the f-QRS complexes (LAS 40 ). Late potential was identified when 2 of the following criteria were satisfied: f-QRS ≥114 ms, RMS 40 o20 µV, or LAS 40 ≥38 ms. 18 We lacked late potential data for 8 patients (VF group: n ¼ 34; non-VF group: n ¼ 101).
Measurement of time-domain TWA
ECGs were recorded using a 24-hour ambulatory ECG device. Time-domain TWA in leads V 5 and V 2 was assessed via the modified moving average method using the MARS PC system (GE Healthcare, Milwaukee, WI) as previously described. 19 In brief, the modified moving average algorithm separates odd and even beats into separate bins and creates median templates for both the odd and even complexes every 15 seconds. These templates then are superimposed, and the entire JT segment is analyzed for alternans. The difference between the odd and even median complexes at any point is defined as the TWA value. We used max TWA during 24-hour ambulatory ECG in lead V 5 or V 2 .
Statistical analysis
Data are given as mean ± SD. The χ 2 test or Student t test was conducted to determine statistically significant differences. Multivariate analysis based on the factors significant by univariate analysis was performed using logistic regression with stepwise forward selection method in a total of 143 Japanese BrS subjects. The predictive value of VF risk was assessed, and the performance of the univariate and logistic model was analyzed by receiver operating characteristic (ROC) analysis. We evaluated cross-validation of the logistic model using the leave-one-out method 20 and internal validation of our logistic model using 2000 bootstrapped samples to form a bias-corrected concordance statistic area under the curve (AUC). Predicted probabilities were compared with observed probabilities using a bias-corrected calibration plot to judge the performance of the model with respect to over-or underestimating the occurrence of VF. Based on logistic regression analysis, we developed a nomogram to estimate the probability of VF occurrence in BrS patients using the rms package in R program. 21 For all tests, Po.05 was considered significant. Statistical analyses were conducted using R and the JMP statistical package (version 8.0J, SAS Institute, Cary, NC).
Results

Comparison of clinical characteristics and noninvasive parameters between VF and non-VF groups in all subjects
Clinical characteristics, 12-leads ECG parameters, signalaveraged ECG parameters, and TWA findings are listed in Table 1 . Age, sex, and family history of SCD were similar in both groups. The prevalences of Sp1 and syncope were higher in the VF group than in the non-VF group (80% vs 51%, P ¼ .004; and 34.3% vs 11.1%, P ¼ .002, respectively).
The following ECG parameters were significantly higher in the VF group than in the non-VF group: r-J interval in lead V 1 
Construction of the prediction model
Multivariate logistic regression analysis and the logistic model are given in Table 2 . The history of syncope, QRS duration in V 6 , r-J interval in V 1 , and Tp-e dispersion remained as independent predictors for VF occurrence with an AUC in ROC curve of 0.869, sensitivity of 97.1%, and specificity of 65.7% (Figure 2A ). The AUCs of the univariate logistic models are shown in Online Supplemental Figure 1 .
Validation of the prediction model
Internal validation was performed by the leave-one-out cross-validation technique. The AUC based on cross-validation was 0.845, with sensitivity of 97.1% and specificity of 63.0% ( Figure 2B ). The bias-corrected AUC for predicting probability of the VF events in our subjects was good (0.8533). The calibration plot demonstrated that the model was well calibrated as a whole, with slight underestimation and overestimation of risk probability (Figure 3) .
Based on the logistic equation including the coefficients in Table 2 , predicted risk probability plots were generated over a range of Tp-e dispersion, QRS duration in V 6 , and r-J interval in V 1 (Figure 4) . For example, a patient without a history of syncope and Tp-e dispersion ¼ 75 has a probability of VF occurrence of 0.375, whereas the probability increases to 0.75 for a patient without history of syncope and Tp-e dispersion ¼ 110.
We further developed a nomogram that can be used to predict individual risk probabilities for VF occurrence based on the logistic model ( Figure 5) . A straight line must be drawn upward to the points to determine how many points a patient will receive for each parameter, and the sum of the points for each predictor must be located on the total point axis. By drawing a straight line downward, the patient's VF probability is found. For example, using this nomogram, a 22-year-old male case with a family history of SCD and Sp1 but without a history of syncope (0 points), r-J interval in V 1 ¼ 84 (35 points), and QRS duration in V 6 ¼ 100 ms (20 points) and Tp-e dispersion ¼ 19 (10 points) receives a total points value ¼ 65. Using the lower scales of the figure, this score corresponds to a probability of VF occurrence of about 0.08 ( Figure 5A ). No VF events were documented in this patient during 105-month follow-up. The other 36-year-old male case with Sp1, without a family history of SCD, with a history of syncope (23 points), r-J interval in V 1 ¼ 103 (45 points), and QRS duration in V 6 ¼ 109 ms (23 points) and Tp-e dispersion ¼ 34 (18 points) receives a total points value ¼ 109. His probability of VF occurrence is about 0.69 ( Figure 5B ). This patient suffered VF 23 months after ICD placement.
BrS risk score and subsequent VF events in BrS cases
An ICD was inserted in all patients of the VF group as secondary prevention and in 47 BrS patients without a history of VF as primary prevention because of (1) Sp1, a family history of SCD, syncope, and VF induction during EPS (n ¼ 4); (2) Sp1, syncope, and VF induction during EPS (n ¼ 7); or (3) Sp1, a family history of SCD, and VF induction during EPS (n ¼ 14), in accordance with the Japanese guidelines. 22, 23 Twenty-two cases with Sp1 desired ICD placement because of VF induction by PES.
During mean follow-up of 82.8 ± 49.0 months (range 6-164 months) after the diagnosis of BrS, VF occurred in 25 of 143 patients. Fifteen of them also had VF history. The Kaplan-Meier event-free survival curves revealed that the rate of VF events was significantly lower in the cases under the cutoff value than over the cutoff value of this logistic model using the log-rank test (P = 2.97 × 10 -8 ; Figure 6 ). In particular, no BrS patient under the cutoff value of this model developed subsequent VF event.
No complications occurred upon ICD placement, and 3 BrS patients suffered inappropriate shocks because of the rapid AF.
Discussion
The major finding of this study was that we established a logistic model consisting of noninvasive parameters to discriminate high-risk and low-risk BrS patients for developing VF. This is an important finding because such discrimination in asymptomatic BrS patients may help to determine the requirements for ICD placement.
History of syncope, Sp1, LAS 40 , max TWA, r-J interval in V 1 , QRS duration in V 6 , and Tp-e dispersion showed significant differences between VF and non-VF group. The logistic regression model constructed by the combination of history of syncope, r-J interval in V 1 , QRS duration in V 6 , and Tp-e dispersion obtained a satisfactory AUC in ROC analysis.
There are no clear standards with regard to appropriate management of BrS patients because the prognosis and highrisk factors of VF occurrence vary based on currently available reports. [2] [3] [4] 24, 25 The management of BrS patients differs slightly in Europe, the United States, and Japan. In Europe and the United States, history of syncope is emphasized as an indication for ICD placement. In Japan, the indication for ICD placement for primary prevention of Quantitative data are given as mean ± SD or n (%). Binary variables were compared by χ2 test, and quantitative traits were tested using the Mann-Whitney U test for univariate analysis. Stepwise logistic analysis was used for multivariate analysis.
CI ¼ confidence interval; Sp1 ¼ spontaneous type 1 Brugada ECG; Tp-e ¼ Tpeak-Tend; TWA ¼ T-wave alternans; VF ¼ ventricular fibrillation. Time-domain TWA can be analyzed from routine 24-hour ambulatory ECG recordings without the requirement for a provocative stimulus and has been reported to be a useful predictor of SCD. 24, 25, 27 Uchimura et al 14 reported that elevated time-domain TWA on ambulatory ECG confirms VF risk with sensitivity of 82% and specificity of 88% in BrS patients. Time-domain TWA has an advantage in BrS patients whose VF frequently occurs during bradycardia or sleep, during periods of parasympathetic nerve predominance. 
Figure 4
Predicted risk probability plots generated over a range of Tp-e dispersion, QRS duration in V 6 , and r-J interval in V 1 .
Many ECG markers, including wide S in type 1 ECG, 30 r-J interval ≥90 ms, QRS duration in V 6 ≥90 ms, 5 QRS fragmentation, 8, 10 Tp-e interval, Tp-e dispersion, 9 and aVR sign, 31 have been reported to contribute toward SCD risk stratification in BrS patients.
In this study, we first constructed a noninvasive logistic model combining history of syncope, r-J interval in V 1 , QRS duration in V 6 , and Tp-e dispersion for VF risk stratification in BrS patients and investigated the efficacy of the model. The AUC was 0.869 with sensitivity of 97.1% and specificity of 65.7%, suggesting a good performance of the logistic model constructed.
In addition, in our model none of the BrS patients under the cutoff value developed a subsequent VF event. Our model achieved high accuracy for predicting VF occurrence using only a subset of noninvasive markers. The nomogram may help clinicians to make appropriate treatment decisions for BrS patients, especially with regard to ICD placement.
The pathogenesis of BrS remains to be completely elucidated. There are many theories based on repolarization and depolarization abnormalities. 32 In our prediction model, both repolarization-and depolarization-related parameters mainly seem to contribute to VF risk.
Study limitation
The limitation of this study is the small number of cases analyzed. The sample size of 143 is too small for the predictive model. Although the adequacy of this scoring method must be validated in a larger prospective study with a longer follow-up period, it could be very useful and convenient for selecting the most appropriate therapeutic option in BrS patients.
Conclusion
Our novel logistic model using previously reported noninvasive risk factors of VF in BrS patients (a combination of history of syncope, r-J interval in V 1 , QRS duration in V 6 , and Tp-e dispersion) is useful for assessing risk stratification in routine clinical practice. 
